LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.27 | 770.25 | 1679 | 7058 | 0.2379 | 0.2761 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.27 | 770.25 | 1372 | 7058 | 0.1944 | 0.1980 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.49 | 770.25 | 1660 | 7555 | 0.2197 | 0.2625 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.49 | 770.25 | 1379 | 7555 | 0.1825 | 0.1934 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.71 | 770.25 | 1700 | 8001 | 0.2125 | 0.2642 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.71 | 770.25 | 1417 | 8001 | 0.1771 | 0.1978 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.94 | 770.25 | 1702 | 8444 | 0.2016 | 0.2580 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.94 | 770.25 | 1448 | 8444 | 0.1715 | 0.2005 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.16 | 770.25 | 1709 | 8892 | 0.1922 | 0.2534 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.16 | 770.25 | 1452 | 8892 | 0.1633 | 0.1968 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.39 | 770.25 | 1710 | 9326 | 0.1834 | 0.2482 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.39 | 770.25 | 1516 | 9326 | 0.1626 | 0.2071 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.61 | 770.25 | 1725 | 9736 | 0.1772 | 0.2465 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.61 | 770.25 | 1531 | 9736 | 0.1573 | 0.2065 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.83 | 770.25 | 1716 | 10078 | 0.1703 | 0.2410 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.83 | 770.25 | 1575 | 10078 | 0.1563 | 0.2127 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.05 | 770.25 | 1705 | 10413 | 0.1637 | 0.2355 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.05 | 770.25 | 1573 | 10413 | 0.1511 | 0.2093 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.27 | 770.25 | 1717 | 10730 | 0.1600 | 0.2348 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.27 | 770.25 | 1598 | 10730 | 0.1489 | 0.2117 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.50 | 770.25 | 1717 | 10991 | 0.1562 | 0.2325 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.50 | 770.25 | 1642 | 10991 | 0.1494 | 0.2182 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.75 | 770.25 | 1709 | 11262 | 0.1517 | 0.2287 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.75 | 770.25 | 1660 | 11262 | 0.1474 | 0.2195 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.98 | 770.25 | 1677 | 11518 | 0.1456 | 0.2206 | MN20160304_L02 | C15 |